Edwards Lifesciences Corporation
Edwards Lifesciences Announces Corporate Vice President Resignation
Summary
On July 21, 2025, Larry L. Wood, Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement and Surgical Structural Heart of Edwards Lifesciences Corporation, notified the Board of Directors of his resignation effective September 1, 2025. Daniel J. Lippis, currently Corporate Vice President, Japan, Greater China and Asia Pacific, will assume the role of Corporate Vice President responsible for Transcatheter Aortic Valve Replacement. This change will be effective from the same date.
Profitelligence Alerts
Get alerts for EW
Be first to know when Edwards Lifesciences Corporation files with the SEC.
Filing Categories
Advertisement
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a leading healthcare company primarily known for its innovative medical devices focused on cardiovascular conditions. The firm's primary function revolves around the development and commercialization of heart valve products and hemodynamic monitoring systems, aimed at enhancing the life quality of patients suffering from cardiovascular diseases. Edwards Lifesciences plays a crucial role in the healthcare sector, particularly impacting the cardiology and surgical fields. Notable for its pioneering work in heart valve therapies, the corporation is at the forefront of transcatheter aortic valve replacement (TAVR) technology, a minimally invasive procedure that offers a significant alternative to traditional open-heart surgeries. Edwards Lifesciences collaborates closely with healthcare professionals to ensure its products address critical medical needs globally. Headquartered in Irvine, California, Edwards Lifesciences operates in a highly competitive and rapidly advancing market, where technological innovation and patient outcomes are pivotal. Its contributions continue to set standards within the medical device industry, reinforcing its market significance by addressing demands for effective cardiovascular care solutions worldwide.
Official SEC Documents
Advertisement